Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Cullinan Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- −5 vs. Q2 2021
- Shares held
- 33.9M
- +1.61M (+5.0%) vs. Q2 2021
- Total value
- $762.3M
- −$66.3M (−8.0%) vs. Q2 2021
- New holders
- 7
- 33 more added
- Sold out
- 12
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 183 | $1.30B |
| Q1 2026 | 174 | $931.0M |
| Q4 2025 | 153 | $653.8M |
| Q3 2025 | 145 | $362.2M |
| Q2 2025 | 144 | $471.4M |
| Q1 2025 | 149 | $489.6M |
| Q4 2024 | 147 | $798.8M |
| Q3 2024 | 137 | $1.09B |
| Q2 2024 | 135 | $1.10B |
| Q1 2024 | 113 | $670.8M |
| Q4 2023 | 113 | $375.6M |
| Q3 2023 | 106 | $344.0M |
| Q2 2023 | 106 | $397.3M |
| Q1 2023 | 103 | $329.5M |
| Q4 2022 | 97 | $397.7M |
| Q3 2022 | 100 | $474.7M |
| Q2 2022 | 89 | $481.7M |
| Q1 2022 | 82 | $386.3M |
| Q4 2021 | 75 | $559.7M |
| Q3 2021 | 66 | $762.3M |
| Q2 2021 | 71 | $828.5M |
| Q1 2021 | 70 | $1.30B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Cullinan Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| US Bancorp | 10 | $0 | 0.00% | +10 | New |
| Wells Fargo & Company | 56 | $1.00K | 0.00% | −7,867−99.3% | Reduced |
| ClariVest Asset Management LLC | 59 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 739 | $17.0K | 0.00% | −26−3.4% | Reduced |
| FourThought Financial, LLC | 775 | $17.0K | 0.00% | +74+10.6% | Added |
| Ameritas Investment Partners, Inc. | 1,984 | $45.0K | 0.00% | +916+85.8% | Added |
| Royal Bank of Canada | 2,810 | $64.0K | 0.00% | +1,903+209.8% | Added |
| Citigroup Inc | 3,171 | $72.0K | 0.00% | +2,304+265.7% | Added |
| STRS Ohio | 3,700 | $83.0K | 0.00% | +500+15.6% | Added |
| UBS Group AG | 3,993 | $90.0K | 0.00% | +2,027+103.1% | Added |
| Legal & General Group Plc | 5,744 | $130.0K | 0.00% | +3,549+161.7% | Added |
| Virtus ETF Advisers LLC | 6,925 | $156.0K | 0.07% | −356−4.9% | Reduced |
| Metropolitan Life Insurance Co | 7,420 | $167.5K | 0.00% | +2,418+48.3% | Added |
| Invesco Ltd. | 9,127 | $205.0K | 0.00% | +9,127 | New |
| Bank of America Corp | 9,264 | $209.0K | 0.00% | −5,372−36.7% | Reduced |
| Credit Suisse AG | 9,534 | $215.0K | 0.00% | +503+5.6% | Added |
| Voya Investment Management LLC | 9,518 | $215.0K | 0.00% | +9,518 | New |
| Bailard, Inc. | 9,600 | $217.0K | 0.01% | +9,600 | New |
| MetLife Investment Management | 9,808 | $221.4K | 0.00% | +3,710+60.8% | Added |
| New York State Common Retirement Fund | 11,848 | $267.0K | 0.00% | +44+0.4% | Added |
| Ensign Peak Advisors, Inc | 12,212 | $276.0K | 0.00% | +7,212+144.2% | Added |
| Manufacturers Life Insurance Company, The | 13,682 | $309.0K | 0.00% | +5,805+73.7% | Added |
| Alliancebernstein L.P. | 13,800 | $311.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 15,139 | $341.0K | 0.00% | +7,015+86.3% | Added |
| Deutsche Bank AG | 15,202 | $343.0K | 0.00% | +6,882+82.7% | Added |
| SG Americas Securities, LLC | 15,863 | $358.0K | 0.00% | +15,863 | New |
| State of Wisconsin Investment Board | 17,100 | $386.0K | 0.00% | +2,028+13.5% | Added |
| California State Teachers Retirement System | 24,668 | $557.0K | 0.00% | +6,420+35.2% | Added |
| Dark Forest Capital Management LP | 25,409 | $573.0K | 0.20% | +11,237+79.3% | Added |
| Swiss National Bank | 28,600 | $646.0K | 0.00% | 00.0% | Unchanged |
| Mirabella Financial Services LLP | 29,686 | $670.0K | 0.09% | +29,686 | New |
| Rhumbline Advisers | 31,025 | $700.0K | 0.00% | +15,998+106.5% | Added |
| Victory Capital Management Inc | 32,250 | $728.0K | 0.00% | −270−0.8% | Reduced |
| Schonfeld Strategic Advisors LLC | 35,858 | $809.0K | 0.01% | +35,858 | New |
| Birchview Capital, LP | 45,114 | $1.02M | 0.69% | 00.0% | Unchanged |
| Morgan Stanley | 70,799 | $1.60M | 0.00% | +4,450+6.7% | Added |
| Bank of New York Mellon Corp | 80,164 | $1.81M | 0.00% | +40,537+102.3% | Added |
| Pura Vida Investments, LLC | 81,418 | $1.84M | 0.14% | −159,380−66.2% | Reduced |
| Artal Group S.A. | 100,000 | $2.26M | 0.06% | 00.0% | Unchanged |
| Citadel Advisors LLC | 106,133 | $2.40M | 0.00% | +3,025+2.9% | Added |
| Goldman Sachs Group Inc | 157,501 | $3.56M | 0.00% | +145,148+1,175.0% | Added |
| Charles Schwab Investment Management Inc | 170,744 | $3.85M | 0.00% | +81,045+90.4% | Added |
| Nuveen Asset Management, LLC | 193,192 | $4.36M | 0.00% | +69,822+56.6% | Added |
| Millennium Management LLC | 207,030 | $4.67M | 0.01% | −26,631−11.4% | Reduced |
| Northern Trust Corp | 229,003 | $5.17M | 0.00% | +96,629+73.0% | Added |
| Logos Global Management LP | 288,458 | $6.51M | 0.47% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 350,000 | $7.90M | 0.11% | 00.0% | Unchanged |
| State Street Corp | 362,959 | $8.19M | 0.00% | +135,116+59.3% | Added |
| Geode Capital Management, LLC | 421,238 | $9.51M | 0.00% | +188,316+80.8% | Added |
| Woodline Partners LP | 475,058 | $10.7M | 0.18% | −86,148−15.4% | Reduced |
| VR Adviser, LLC | 706,050 | $15.9M | 2.05% | −270,095−27.7% | Reduced |
| BVF Inc | 735,106 | $16.6M | 0.65% | 00.0% | Unchanged |
| Franklin Resources Inc | 776,406 | $17.5M | 0.01% | −1,092−0.1% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 1,044,000 | $23.6M | 0.46% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,074,082 | $24.2M | 0.85% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 1,075,912 | $24.3M | 0.51% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,146,145 | $25.9M | 0.29% | 00.0% | Unchanged |
| American International Group, Inc. | 1,237,877 | $27.9M | 0.15% | +6,756+0.5% | Added |
| Eventide Asset Management, LLC | 1,440,145 | $31.7M | 0.42% | 00.0% | Unchanged |
| BlackRock Inc. | 1,629,594 | $36.8M | 0.00% | +687,316+72.9% | Added |
| Baupost Group LLCSuperinvestorBaupost Group | 1,835,560 | $40.2M | 0.37% | 00.0% | Unchanged |
| CHI Advisors LLC | 2,244,841 | $50.7M | 14.79% | +2,000+0.1% | Added |
| Vanguard Group Inc | 2,281,451 | $51.5M | 0.00% | +1,125,686+97.4% | Added |
| FMR LLC | 2,500,212 | $56.4M | 0.00% | +522,305+26.4% | Added |
| Foresite Capital Management V, LLC | 2,731,410 | $61.6M | 19.16% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 7,648,268 | $172.6M | 26.78% | −265,619−3.4% | Reduced |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −295,596−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −163,880−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −78,000−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −75,732−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −74,951−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −60,319−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −39,113−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −25,982−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −2,912−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −2,273−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |